Quarterly report · Q3
3750.TEDINET S100STK6
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.4bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥2.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.7bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | −¥495m | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | −¥516m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | −¥595m | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | −¥862m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥602m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | −¥533m | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | −¥710m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥553m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥723m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥552m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | −¥723m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥13.7bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥14.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥14.1bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.6bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥11.4bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.1bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥2.7bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.0bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥716m | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-61.9 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-30.31 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-118.71 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-80.95 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-18.09 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 13.7% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.7% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-12-31 | −¥134m |
| jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥102m |
| jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥102m |
| jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segment | segment profit | 2023-04-01 → 2023-12-31 | −¥418m |
| jpcrp040300-q3r_E05443-000Real Asset Managementreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q3r_E05443-000Real Asset Managementreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q3r_E05443-000Real Asset Managementreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥58m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥1.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥1.4bn |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | −¥360m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | −¥116m |
| jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥128m |
| jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥128m |
| jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥224m |
| jpcrp040300-q3r_E05443-000Real Asset Managementreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E05443-000Real Asset Managementreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E05443-000Real Asset Managementreportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥176m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥1.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥1.7bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | −¥400m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 333
| Item | Context | Value | Unit |
|---|---|---|---|
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数は、100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Voting rights (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | Original text (Japanese)一単元（100株）未満の株式 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)㈱サイトリ細胞研究所 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都千代田区大手町１－１－１ | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |